Novo Holdings A/S’s Treace Medical Concepts TMCI Stock Holding History

Novo Holdings A/S’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-360,000	Closed	-$4.7M	–	41
2024 Q1	$4.7M	Hold	360,000	–	–	0.32%	32
2023 Q4	$4.59M	Hold	360,000	–	–	0.28%	32
2023 Q3	$4.72M	Hold	360,000	–	–	0.35%	34
2023 Q2	$9.21M	Sell	360,000 -180,000	-33%	-$4.65M	0.71%	33
2023 Q1	$13.6M	Sell	540,000 -97,317	-15%	-$2.28M	0.9%	32
2022 Q4	$14.7M	Buy	637,317 +49,009	+8%	+$1.13M	0.91%	30
2022 Q3	$13M	Hold	588,308	–	–	0.62%	29
2022 Q2	$8.44M	Buy	588,308 +87,887	+18%	+$1.48M	0.42%	42
2022 Q1	$9.46M	Hold	500,421	–	–	0.5%	35
2021 Q4	$9.33M	Buy	500,421 +216,652	+76%	+$4.47M	0.44%	32
2021 Q3	$7.63M	Sell	283,769 -39,231	-12%	-$1.08M	0.39%	36
2021 Q2	$10.1M	Buy	+323,000	New	+$10.3M	0.45%	35

Other funds holding TMCI

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Novo Holdings A/S's TMCI Position: Q2 2024 in Review

Novo Holdings A/S sold out of Treace Medical Concepts (TMCI) in Q2 2024, closing a stake of 360,000 shares — an estimated $4.7M sold.

Novo Holdings A/S first reported a position in TMCI in Q2 2021 and held it in 12 quarters. The position peaked at $14.7M in Q4 2022. 127 funds tracked by Wall St. Rank hold TMCI as of Q2 2024.

Novo Holdings A/S reported no remaining Treace Medical Concepts position as of Q2 2024 after selling out during the quarter.
Novo Holdings A/S sold 360,000 Treace Medical Concepts shares in Q2 2024, an estimated $4.7M.
Novo Holdings A/S first reported a position in Treace Medical Concepts in Q2 2021 and held it in 12 quarters.
Novo Holdings A/S's Treace Medical Concepts position peaked at $14.7M in Q4 2022.
127 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2024.

Based on Novo Holdings A/S's 13F filing for Q2 2024, filed 14 Aug 2024.